• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Mallinckrodt

A shot from Prime Time Endos branded Peyronies commercial
Marketing

Endo builds on ‘Bent Carrot’ campaign for fresh Xiaflex push

Four years on from its original “Bent Carrot” ad, Endo returned to the campaign for a TV spot that looks at how a man sought treatment for Peyronie’s.
Nick Paul Taylor Aug 12, 2025 12:59pm
merger MA combined company mergers  acquisitions business development

Troubled Mallinckrodt, Endo telegraph $6.7B merger plans

Mar 13, 2025 10:18am
Mallinckrodt

BMJ report digs into Mallinckrodt's opioid selling tactics

Jun 10, 2024 6:30pm
A gavel in the foreground with the scale of justice in the background

Mallinckrodt wins court go-ahead for 2nd bankruptcy

Oct 11, 2023 10:55am
Bankruptcy

After $1.7B opioid deal, Mallinckrodt readies 2nd bankruptcy bid

Aug 23, 2023 2:19pm
Mallinckrodt

Troubled Mallinckrodt continues to weigh its financial options

Aug 9, 2023 9:24am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings